CY1123476T1
(en )
2022-03-24
NUCLEAR TRANSPORT MODIFIERS AND THEIR USES
IL264541B
(en )
2019-09-26
Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
WO2014205389A8
(en )
2015-04-02
Nuclear transport modulators and uses thereof
IL253225B
(en )
2021-03-25
Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis b
IL242141B
(en )
2019-09-26
Sulphamoylthiophenamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
IL241110A0
(en )
2015-11-30
N-phenyl-carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
DK2819726T3
(en )
2019-11-18
STANDARD DOSAGE ADMINISTRATION DEVICE
JO3310B1
(en )
2018-09-16
Indolezine derivatives are new and a method for their production and the pharmaceutical formulations they contain
UA116395C2
(en )
2018-03-12
TRIASOL DERIVATIVES [4,5-b] PYRIMIDINE
DK2773633T3
(en )
2017-11-13
Heterocyclic compounds, medicaments containing the compounds, their use and processes for their preparation.
SI3069720T1
(en )
2020-02-28
A pharmaceutical composition containing glutarimide derivatives and its use for the treatment of eosinophilic diseases
ZA201505318B
(en )
2016-03-30
2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions
LT2939665T
(en )
2019-07-25
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HIV INFECTIONS
MX2014014308A
(en )
2015-02-12
Pyrrolidino heterocycles.
LT3421033T
(en )
2022-11-10
A COMPOSITION OF ATAZANAVIR AND COBICISTAT FOR THE TREATMENT OF HIV
TH148754B
(en )
2016-04-18
Compounds for the treatment and prevention of respiratory syndromes.
TH1501000987A
(en )
2016-11-09
Sulfamoyl arylamide and its use as a drug for the treatment of hepatitis B.
TH148806B
(en )
2016-04-18
Improved stability of the pharmaceutical formulation.